en · de · es · pt
melanotan-2-notes.peptides7501.com › Blog › Melanotan-2 Identity And Regulatory Status — Explained

Melanotan-2 Identity And Regulatory Status — Explained

By Editorial Desk · published 2025-10-24 · last reviewed 2025-12-02 · Blog

A practical reference on reference standard: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-12-02 and is reviewed periodically as new material appears.

Melanotan-2 Identity And Regulatory Status

Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.

Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.

Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.

Storage, Verification and Regulatory Status

Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.

Melanotan-2 at a glance

PropertyValueNotes
Chemical classSynthetic cyclic heptapeptideAnalogue of alpha-melanocyte-stimulating hormone
Common synonymsMT-II; melanotan 2No internationally accepted non-proprietary name
Typical presentationLyophilised powder in a sealed vialOften supplied alongside a separate diluent
Regulatory statusUnapproved therapeutic substanceCustoms seizure reported in several jurisdictions
Reported route in useSubcutaneous injectionSelf-administered outside clinical settings

Background and Mechanism of Melanotan-2

Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.

Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.

Related pages on this site

Regulatory Status and Analytical Detection

The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.

Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.

Supporting material

=== Fibroblast growth factor === fibroblast growth factor (FGF-21) has been recently characterized as a potent metabolic regulator. Systemic administration of FGF-21 reduced plasma glucose and triglycerides to near normal levels in genetically compromised diabetic rodents. FGF21 can function as a crucial regulator mediating beneficial metabolic effects of therapeutic agents such as metformin, glucagon/glucagonlike peptide1analogues, thiazolidinedione, sirtuin 1 activators, and lipoic acid. A study showed that when fibroblast growth factor-21 administered daily for 6 weeks to diabetic rhesus monkeys, it caused a dramatic decline in fasting plasma glucose, fructosamine, triglycerides, insulin and glucagon. In a significant point during the study, FGF-21 administration also led to significant improvements in lipoprotein profiles and a beneficial changes in the circulating levels of several cardiovascular risk markers. And the induction of a small but significant weight loss. These data support the development of FGF-21 for the treatment of diabetes and other metabolic diseases.

=== EC 1.1.99 With unknown physiological acceptors === EC 1.1.99.1: choline dehydrogenase EC 1.1.99.2: L-2-hydroxyglutarate dehydrogenase EC 1.1.99.3: gluconate 2-dehydrogenase (acceptor) EC 1.1.99.4: dehydrogluconate dehydrogenase EC 1.1.99.5: now EC 1.1.5.3, glycerol-3-phosphate dehydrogenase EC 1.1.99.6: D-2-hydroxy-acid dehydrogenase EC 1.1.99.7: lactate—malate transhydrogenase EC 1.1.99.8: Now EC 1.1.2.7, methanol dehydrogenase (cytochrome c) and EC 1.1.2.8, alcohol dehydrogenase (cytochrome c).

In chemistry, yield, also known as reaction yield or chemical yield, refers to the amount of product obtained in a chemical reaction. Yield is one of the primary factors that scientists must consider in organic and inorganic chemical synthesis processes. In chemical reaction engineering, "yield", "conversion" and "selectivity" are terms used to describe ratios of how much of a reactant was consumed (conversion), how much desired product was formed (yield) in relation to the undesired product (selectivity), represented as X, Y, and S. The term yield also plays an important role in analytical chemistry, as individual compounds are recovered in purification processes in a range from quantitative yield (100 %) to low yield (< 50 %).

Sources: en.wikipedia.org

Notes from published material

=== Arrival in Washington === Nixon had been elected in 1968 on the promise of achieving "peace with honor" and ending the Vietnam War. By promising to continue the peace talks which Johnson began in May 1968 in Paris, Nixon admitted that he had ruled out "a military victory" in Vietnam. Nixon wanted a diplomatic settlement similar to the armistice of Panmunjom that ended the Korean War and frequently stated in private he had no intention of being "the first president of the United States to lose a war". To force the North Vietnamese to sign an armistice, Nixon favored a two-pronged approach of the "madman theory" of seeking to act rashly to intimidate the North Vietnamese while at the same time trying using the strategy of "linkage" to improve relations with the Soviet Union and China in order to persuade both these nations to stop sending arms to North Vietnam. In office, Nixon implemented a policy of Vietnamization that aimed to gradually withdraw U.S. troops while expanding the combat role of the South Vietnamese Army so that it would be capable of independently defending its government against the National Front for the Liberation of South Vietnam, a Communist guerrilla organization, and the North Vietnamese army (Vietnam People's Army or PAVN). Kissinger was opposed to Vietnamization.

By 1987, companies selling lasers were claiming that they could treat pain, accelerate healing of sports injuries, and treat arthritis, but there was little evidence for this at that time. Mester originally called this approach "laser biostimulation", but it soon became known as "low-level laser therapy". With the adaptation of light emitting diodes it became known as "low-level light therapy"; to resolve confusion around the exact meaning of "low level", the term "photobiomodulation" arose as a synonym.

. In the latter case, increasing the polymer chain length 10-fold would increase the viscosity over 1000 times. Increasing chain length furthermore tends to decrease chain mobility, increase strength and toughness, and increase the glass-transition temperature (Tg). This is a result of the increase in chain interactions such as van der Waals attractions and entanglements that come with increased chain length. These interactions tend to fix the individual chains more strongly in position and resist deformations and matrix breakup, both at higher stresses and higher temperatures.

Sources: en.wikipedia.org

Background from the literature

====== Nano-DESI ====== One of the possible ways to measure the content of single cells is nano-DESI (nanospray desorption electrospray ionization). Unlike desorption electrospray ionization, which is a desorption technique, nano-DESI is a liquid extraction technique that enables the sampling of small surfaces, therefore suitable for single-cell analysis. In nano-DESI, two fused silica capillaries are set up in a V-shaped form, closing an angle of approx. 85 degrees. The two capillaries are touching therefore a liquid bridge can be formed between them and enable the sampling of surfaces as small as a single cell. The primary capillary delivers the solvent to the sample surface where the extraction happens and the secondary capillary directs the solvent with extracted molecules to the MS inlet. Nano-DESI mass spectrometry (MS) enables sensitive molecular profiling and quantification of endogenous species as small as a few hundred fmol-s in single cells in a higher throughput manner. Lanekoff et al. identified 14 amino acids, 6 metabolites, and several lipid molecules from single cheek cells using nano-DESI MS.

Although both the three- and four-star ratings specify the same storage times and same minimum temperature of −18 °C (0 °F), only a four-star freezer is intended for freezing fresh food, and may include a "fast freeze" function (runs the compressor continually, down to as low as −26 °C (−15 °F)) to facilitate this. Three (or fewer) stars are used for frozen food compartments that are only suitable for storing frozen food; introducing fresh food into such a compartment is likely to result in unacceptable temperature rises. This difference in categorization is shown in the design of the 4-star logo, where the "standard" three stars are displayed in a box using "positive" colours, denoting the same normal operation as a 3-star freezer, and the fourth star showing the additional fresh food/fast freeze function is prefixed to the box in "negative" colours or with other distinct formatting. Most European refrigerators include a moist cold refrigerator section (which does require (automatic) defrosting at irregular intervals) and a (rarely frost-free) freezer section.

==== Operation Enduring Freedom – Trans Sahara ==== In June 2005, the United States replaced the PSI with the launch of the Trans-Saharan Counterterrorism Initiative (TSCTI/TSCTP) for Burkina Faso, Mali, Niger, Chad, Mauritania, Morocco, Algeria, Tunisia, Senegal and Nigeria, with the support from the Department of Defense's Operation Enduring Freedom – Trans Sahara (OEF-TS). The principle SOF unit for the TSCTP/TSCTI was the 10th SFG, which was joined by the 20th SFG, as the 3rd SFG (who had regional responsibility for Africa) was assigned to Iraq. This meant the Green Berets in the region lacked the cultural and language prerequisites that the 3rd SFG had, and so the Green Berets were forced into a mission that they, like the targeted countries were "learning on the job". In 2005 and 2007, US Army Special Forces and US Army Rangers, along with contingents from other units participated in the JCET's Flintlock Exercises, where they provided training experience both for American troops and for troops of African countries. Small numbers of European troops were also involved in these exercises. The first test of the TSCTI, which "kicked off" the Saharan counterterrorism initiative was Flintlock 2005, lasted from 6–26 June 2005, and was designated by the Bush administration as the largest American military exercise in Africa since World War II. 700 special forces participants, supported by an additional 2,100 troops from 9 North and West African states.

=== β-glucan/chitin complex === The β-glucan/chitin complex refers to the combination of two natural polysaccharides (β-glucan and chitin) found in fungal cell walls. This complex is a major component found in a variety of fungal cell walls and are also found in certain plants, algae, and bacteria. β-glucan contributes to the structural strength of the cell wall and plays roles in cell signaling, immune modulation and defense against pathogens. Chitin is a long-chain polymer of N-acetylglucosamine units, linked by β-glycosidic bonds. It provides structural support and protection to fungal cells, contributing to their rigidity and resilience. The addition of this complex to the growth components that make up the initial matrix that is the base of these emerging biotextiles provides a significant effect on the durability and usefulness of the processed result.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II approved for medical use?

No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.

Where did melanotan II originate?

It was developed in the 1980s by researchers investigating analogues of alpha-melanocyte-stimulating hormone for pigmentation and related endpoints. Early work included small human studies during the 1990s. Development did not progress to licensing, and the compound remained a research and grey-market item.

Why is purity a concern for unapproved peptides?

Peptides are prone to truncation, oxidation and aggregation during synthesis and handling. Without independent testing, a buyer cannot confirm the identity or the content of a vial. Analytical surveys of unapproved peptide products have repeatedly found discrepancies between label claims and measured composition.

How should the powder be stored?

The lyophilised solid is best kept cold, dry and dark, typically at minus twenty degrees Celsius. Moisture and repeated warming cycles are the main causes of degradation. Solutions prepared from the powder are less stable and are normally used quickly.

Network